Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000310076 | SCV000365994 | uncertain significance | Wolman disease | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000310076 | SCV000365995 | uncertain significance | Wolman disease | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000733561 | SCV000861640 | likely benign | not specified | 2018-06-05 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000944060 | SCV001090020 | benign | Lysosomal acid lipase deficiency | 2019-12-31 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000944060 | SCV001453547 | benign | Lysosomal acid lipase deficiency | 2020-09-16 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004544509 | SCV004771396 | likely benign | LIPA-related disorder | 2021-06-07 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |